A detailed history of Arcadia Investment Management Corp transactions in Vericel Corp stock. As of the latest transaction made, Arcadia Investment Management Corp holds 515 shares of VCEL stock, worth $24,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
515
Holding current value
$24,040
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$32.52 - $52.33 $16,747 - $26,949
515 New
515 $26,000
Q4 2022

Feb 08, 2023

BUY
$17.65 - $27.37 $17,650 - $27,370
1,000 New
1,000 $26,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.2B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.